Log In
BCIQ
Print this Print this
 

Retinal pigment epithelial (RPE) cell therapy

Also known as: hESC-derived hRPE cells, MA09-hRPE cells

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionHuman embryonic stem cell-derived retinal pigment epithelium (RPE) cells
Molecular Target Not applicable
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$379.0M

$379.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/10/2016

$379.0M

$379.0M

0

Get a free BioCentury trial today